Silvercrest Asset Management Group LLC Protagonist Therapeutics, Inc Transaction History

Silvercrest Asset Management Group LLC

$13.6 Billion
Q1 2025

A detailed history of Silvercrest Asset Management Group LLC transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 54,723 shares of PTGX stock, worth $2.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

54,723

Previous 84,426 35.18%

Holding current value

$2.6 Million

Previous $3.26 Million 18.78%

% of portfolio

0.02%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$35.09 - $59.76 $1.04 Million - $1.78 Million	-29,703 Reduced 35.18%	54,723 $2.65 Million
Q4 2024 Feb 14, 2025	SELL	$38.51 - $48.43 $31,886 - $40,100	-828 Reduced 0.97%	84,426 $3.26 Million
Q3 2024 Nov 14, 2024	SELL	$33.72 - $47.33 $3.57 Million - $5.01 Million	-105,914 Reduced 55.4%	85,254 $3.83 Million
Q2 2024 Aug 14, 2024	SELL	$24.66 - $34.8 $4.71 Million - $6.65 Million	-191,168 Reduced 50.0%	191,168 $6.62 Million
Q2 2024 Aug 14, 2024	BUY	$24.66 - $34.8 $4.77 Million - $6.74 Million	193,593 Added 102.57%	382,336 $13.2 Million
Q1 2024 May 15, 2024	BUY	$21.79 - $32.15 $179,702 - $265,141	8,247 Added 4.57%	188,743 $5.46 Million
Q4 2023 Feb 14, 2024	BUY	$14.05 - $23.44 $477 - $796	34 Added 0.02%	180,496 $4.14 Million
Q3 2023 Nov 14, 2023	BUY	$16.68 - $23.66 $871,780 - $1.24 Million	52,265 Added 40.77%	180,462 $3.01 Million
Q2 2023 Aug 14, 2023	BUY	$18.02 - $29.36 $267,452 - $435,761	14,842 Added 13.09%	128,197 $3.54 Million
Q1 2023 May 15, 2023	SELL	$10.78 - $25.38 $1.37 Million - $3.23 Million	-127,390 Reduced 52.91%	113,355 $2.61 Million
Q4 2022 Feb 14, 2023	SELL	$7.36 - $11.17 $16,692 - $25,333	-2,268 Reduced 0.93%	240,745 $2.63 Million
Q3 2022 Nov 14, 2022	BUY	$7.86 - $11.71 $1.01 Million - $1.5 Million	128,254 Added 111.76%	243,013 $2.05 Million
Q2 2022 Aug 15, 2022	SELL	$7.06 - $25.52 $35,829 - $129,514	-5,075 Reduced 4.24%	114,759 $908,000
Q1 2022 May 16, 2022	BUY	$23.34 - $36.08 $26,117 - $40,373	1,119 Added 0.94%	119,834 $2.84 Million
Q4 2021 Feb 14, 2022	BUY	$17.63 - $37.1 $835,168 - $1.76 Million	47,372 Added 66.4%	118,715 $4.06 Million
Q3 2021 Nov 15, 2021	SELL	$12.95 - $49.69 $622,221 - $2.39 Million	-48,048 Reduced 40.24%	71,343 $1.26 Million
Q2 2021 Aug 16, 2021	BUY	$25.57 - $44.88 $3.05 Million - $5.36 Million	119,391 New	119,391 $5.36 Million

Others Institutions Holding PTGX

# of Institutions

299

Shares Held

61.3M

Call Options Held

1.01M

Put Options Held

555K

View Full List

About Protagonist Therapeutics, Inc

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2.33B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

More about PTGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.

Account

Silvercrest Asset Management Group LLC Protagonist Therapeutics, Inc Transaction History